类有机物
呼吸系统
疾病
医学
药物开发
诱导多能干细胞
呼吸道疾病
药物发现
精密医学
个性化医疗
呼吸生理学
肺病
计算生物学
生物信息学
生物
药品
肺
神经科学
重症监护医学
模式生物
作者
Lanhe Chu,Dian Chen,Simin Jiang,Huanyu Long,Xiaojuan Liu,Yahong Chen
出处
期刊:Biomedicines
[Multidisciplinary Digital Publishing Institute]
日期:2026-01-20
卷期号:14 (1): 221-221
被引量:1
标识
DOI:10.3390/biomedicines14010221
摘要
Organoid culture represents a sophisticated biological model that surpasses traditional two-dimensional (2D) methods and animal models in physiological relevance and cost-effectiveness. Current organoid systems derive from adult, fetal, and induced pluripotent stem cells, providing innovative platforms for studying organ development, disease pathogenesis, and drug discovery. Recent technological advances now enable respiratory organoids to significantly contribute to respiratory disease research. This review comprehensively synthesizes the development of respiratory organoid models and their applications in studying major respiratory diseases, including pulmonary fibrosis, chronic obstructive pulmonary disease (COPD), and lung cancer. It further evaluates the transformative potential of these models in advancing respiratory disease research. Respiratory organoids uniquely model disease mechanisms and drug responses in human-specific microenvironments, enabling pathogenesis studies of respiratory diseases. They serve as functional platforms for drug screening and personalized therapy development. Future integration of multi-organoid systems with precision medicine promises to redefine respiratory disease research paradigms.
科研通智能强力驱动
Strongly Powered by AbleSci AI